We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Can Clorox's Strategic Initiatives & Pricing Power Growth?
Read MoreHide Full Article
Key Takeaways
Clorox leverages pricing strength, cost savings and IGNITE to bolster growth and margins.
Advanced analytics support CLX's dual pricing strategy to balance value and profitability.
All three core business units posted year-over-year growth in Q4 fiscal 2025.
The Clorox Company’s (CLX - Free Report) holistic margin-management efforts, constant product innovations and IGNITE strategy progress well. Clorox is effectively capitalizing its pricing strength to support growth and mitigate cost pressures. The company is benefiting from ongoing efforts to improve efficiency across manufacturing and logistics, as well as from portfolio changes like the VMS divestiture.
The company has been proactively adjusting its pricing strategy to address inflation and shifting consumer behaviors. CLX’s multi-faceted pricing policy includes premium pricing for its core brands, with a focus on premiumization and value for consumers. Our model anticipates price/mix/other to grow 0.1% in fiscal 2026.
Clorox has strategically leveraged advanced analytics to identify price inflection points, with a “dual pricing” strategy that selectively reduces prices on value-sensitive SKUs while increasing promotional support on higher-margin products. This approach enables the company to balance affordability for consumers with sustained profitability, reinforcing gross margin expansion amid soft volume trends.
Clorox continues to deliver impressive results, benefiting from disciplined pricing actions, a comprehensive margin-management program and cost-saving initiatives that have steadily bolstered margins. It delivered flat gross margin in fourth-quarter fiscal 2025, following an expansion for ten straight quarters in the preceding quarter. CLX’s streamlined operating model targets improving efficiency. It demonstrated broad-based segment strength in fourth-quarter fiscal 2025, with all three core business units posting solid year-over-year growth,
CLX has been evaluating potential reformulations with product improvements and select strategic pricing actions. The company concentrates on offering superior value to consumers by investing in its brands and making innovations. Clorox remains focused on advancing its transformation to become a strong and resilient company.
CLX’s Price Performance, Valuation & Estimates
Shares of Clorox have lost 24.7% year to date compared with the industry’s decline of 8.1%.
Image Source: Zacks Investment Research
From a valuation standpoint, CLX trades at a forward price-to-earnings ratio of 19.73X compared with the industry’s average of 19.12X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for CLX’s fiscal 2026 earnings implies a year-over-year decline of 21.5%, while that of fiscal 2027 shows growth of 14.1%. The company’s EPS estimate for fiscal 2026 and fiscal 2027 has been stable in the past 30 days.
Image Source: Zacks Investment Research
Clorox stock currently carries a Zacks Rank #4 (Sell).
The Zacks Consensus Estimate for The Chefs' Warehouse’s current financial-year sales and earnings indicates growth of 6.6% and 19.1%, respectively, from the prior-year levels. CHEF delivered a trailing four-quarter earnings surprise of 11.3%, on average.
Celsius Holdings, Inc. (CELH - Free Report) , which is specialized in nutritional functional foods, beverages and dietary supplements, starches and nutrition ingredients, currently sports a Zacks Rank of 1.
The Zacks Consensus Estimate for Celsius’ current financial-year earnings is expected to rise 54.3% from the corresponding year-ago reported figure. CELH delivered a trailing four-quarter earnings surprise of 5.4%, on average.
Post Holdings (POST - Free Report) , which is a consumer-packaged goods holding company, currently carries a Zacks Rank #2 (Buy). POST delivered a trailing four-quarter earnings surprise of 21.4%, on average.
The Zacks Consensus Estimate for Post Holdings’ current financial-year earnings indicates growth of 11% from the year-ago number.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Can Clorox's Strategic Initiatives & Pricing Power Growth?
Key Takeaways
The Clorox Company’s (CLX - Free Report) holistic margin-management efforts, constant product innovations and IGNITE strategy progress well. Clorox is effectively capitalizing its pricing strength to support growth and mitigate cost pressures. The company is benefiting from ongoing efforts to improve efficiency across manufacturing and logistics, as well as from portfolio changes like the VMS divestiture.
The company has been proactively adjusting its pricing strategy to address inflation and shifting consumer behaviors. CLX’s multi-faceted pricing policy includes premium pricing for its core brands, with a focus on premiumization and value for consumers. Our model anticipates price/mix/other to grow 0.1% in fiscal 2026.
Clorox has strategically leveraged advanced analytics to identify price inflection points, with a “dual pricing” strategy that selectively reduces prices on value-sensitive SKUs while increasing promotional support on higher-margin products. This approach enables the company to balance affordability for consumers with sustained profitability, reinforcing gross margin expansion amid soft volume trends.
Clorox continues to deliver impressive results, benefiting from disciplined pricing actions, a comprehensive margin-management program and cost-saving initiatives that have steadily bolstered margins. It delivered flat gross margin in fourth-quarter fiscal 2025, following an expansion for ten straight quarters in the preceding quarter. CLX’s streamlined operating model targets improving efficiency. It demonstrated broad-based segment strength in fourth-quarter fiscal 2025, with all three core business units posting solid year-over-year growth,
CLX has been evaluating potential reformulations with product improvements and select strategic pricing actions. The company concentrates on offering superior value to consumers by investing in its brands and making innovations. Clorox remains focused on advancing its transformation to become a strong and resilient company.
CLX’s Price Performance, Valuation & Estimates
Shares of Clorox have lost 24.7% year to date compared with the industry’s decline of 8.1%.
Image Source: Zacks Investment Research
From a valuation standpoint, CLX trades at a forward price-to-earnings ratio of 19.73X compared with the industry’s average of 19.12X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for CLX’s fiscal 2026 earnings implies a year-over-year decline of 21.5%, while that of fiscal 2027 shows growth of 14.1%. The company’s EPS estimate for fiscal 2026 and fiscal 2027 has been stable in the past 30 days.
Image Source: Zacks Investment Research
Clorox stock currently carries a Zacks Rank #4 (Sell).
Stocks to Consider in the Consumer Staples Space
The Chefs' Warehouse, Inc. (CHEF - Free Report) distributes specialty food and center-of-the-plate products in the United States, the Middle East and Canada. It currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for The Chefs' Warehouse’s current financial-year sales and earnings indicates growth of 6.6% and 19.1%, respectively, from the prior-year levels. CHEF delivered a trailing four-quarter earnings surprise of 11.3%, on average.
Celsius Holdings, Inc. (CELH - Free Report) , which is specialized in nutritional functional foods, beverages and dietary supplements, starches and nutrition ingredients, currently sports a Zacks Rank of 1.
The Zacks Consensus Estimate for Celsius’ current financial-year earnings is expected to rise 54.3% from the corresponding year-ago reported figure. CELH delivered a trailing four-quarter earnings surprise of 5.4%, on average.
Post Holdings (POST - Free Report) , which is a consumer-packaged goods holding company, currently carries a Zacks Rank #2 (Buy). POST delivered a trailing four-quarter earnings surprise of 21.4%, on average.
The Zacks Consensus Estimate for Post Holdings’ current financial-year earnings indicates growth of 11% from the year-ago number.